Francesco Granata
PROFESSIONAL EXPERIENCE
Francesco Granata is Industrial Partner at FSI. He has a solid and extensive experience in pharmaceutical and biotechnology sectors both in Italy and internationally.
Francesco Granata was Executive Vice President and Member of the Executive Committee of Biogen Idec (NASDAQ: BIIB), one of the leading global biotech companies based in Boston. Previously he was Group Vice President and President of Schering-Plough Europe and Canada. Previously, he held management positions at Pfizer and was CEO of Pharmacia and Dompé Biotech. He began his career in the pharmaceutical world in the Research and Development sector, where he held roles of increasing responsibility both at Italian and international level. In particular, he was medical director for Italy and Southern Europe for GSK, responsible for the clinical development of the molecules discovered in the Italian Research Center and Board Member of GSK International Research.
Francesco has served as a member of several industry associations: Board Member of Farmindustria (Italy), Head of Italian LAWG, Chairman of Pharma Heads of Europe Committee, Co-Chairman of EFPIA Heads of Europe Committee and Board member of EFPIA.
Francesco Granata has a solid background in international Private Equity sector and Venture Capital, for his past cooperation with several Private Equity companies, alike Warburg Pincus ed Ardian, and for being the co-founder of Venture Capital 3B Future.
In the past Francesco Granata has been Chairman of the Board and Board Member of several international companies, like Circassia Group(UK), Kyowa Kirin International (Giappone, UK), Prismic (USA), Helsinn (CH), Sintetica (CH), Neopharmed Gentili (Italy).
In Italy Francesco Granata currently sits on the Boards of Italfarmaco (where he is also member of the R&D committee) and GreenBone Ortho (a med-tech sector start up). Internationally, he is President of Kelix Bio (UK) and he is Venture Partner and Member of 3B Future Health Fund Investment Committee (a venture capital fund focusing on oncology in Luxembourg).
EDUCATION
He is a medical doctor and he holds a degree from Pavia University.